Wesley Burkett, MD

Wesley Burkett, MD, discusses some novel targets that are available and being evaluated in the endometrial cancer space.

Wesley Burkett, MD, discusses the next steps for treating patients with endometrial cancer.

Wesley Burkett, MD, adiscusses his excitement for the approval of pembrolizumab in combination with lenvatinib for patients with advanced endometrial carcinoma that is not microsatellite instability-high or mismatch repair deficient.

Wesley Burkett, MD, discusses treatment options for endometrial cancer.

Wesley Burkett, MD, discusses a preclinical study of dietary intervention for patients with endometrial cancer.